Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Carcinoma in Situ

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Carcinoma in Situ in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arriagada, R; Gilles, R; Guinebretière, JM; Lucidarme, O; Meunier, M; Neuenschwander, S; Rochard, F; Tardivon, AA; Vanel, D; Zafrani, B1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Carcinoma in Situ

ArticleYear
Ductal carcinoma in situ: MR imaging-histopathologic correlation.
    Radiology, 1995, Volume: 196, Issue:2

    Topics: Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Contrast Media; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity

1995